Accelerated development of 13-step intermediate to reduce time to market

Global top 15 US Pharma Co.

Theme	Accelerated development of 13-step intermediate to reduce time to market
Partner	Global top 15 US Pharma Co.
Context	Pharma Co. looking to: -Move away from EU suppliers (due to high cost) -Partner with non-China suppliers to develop a complex non-pyridine based active Prior relationship of 8+ yrs.
What Ingrevia did	Synthesized complex intermediate involving a 13+ Step chemistry Re-engineered route of synthesis to ensure even effluents are non-hazardous Collaborated with Group Co. to supply active, synthesized from the intermediate
Outcome	Synthesis to active production in 5 months (faster than in-house route) Outsourced supply chain Comprehensive solution provided – Synthesis to production

Let’s build what’s next

Start a conversation with Jubilant Ingrevia and engage the teams delivering at scale across our businesses. Share your interest, and we’ll connect you with the right leaders to take it forward.

Accelerated development of 13-step intermediate to reduce time to market